Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026

Fractyl Health (Nasdaq: GUTS) will report fourth quarter and full year 2025 financial results and provide business updates on March 24, 2026 at 4:30 p.m. ET.

Rhea-AI Summary

Fractyl Health (Nasdaq: GUTS) will report fourth quarter and full year 2025 financial results and provide business updates on March 24, 2026 at 4:30 p.m. ET. A live webcast and presentation will be available in the company’s Events section at http://ir.fractyl.com and archived for replay after the live event.

Argus Mar 17 session

-0.20% close to close Open Argus

Details

News Market Reaction – GUTS

On Mar 17, the day this news came out, GUTS closed 0.20% below the previous close.

Data tracked by StockTitan Argus for the Mar 17 session.

Key Figures

Earnings call date: March 24, 2026 Earnings call time: 4:30 p.m. ET

Earnings call date

March 24, 2026

Scheduled Q4 and full-year 2025 results release

Earnings call time

4:30 p.m. ET

Start time of webcasted conference call

Historical Context

5 past events · Latest: Feb 26

5 events

1. Feb 26

   Clinical milestone

   24h Move

   -6.2%

   Completion of REMAIN-1 pivotal cohort randomization and timeline to FDA filing.

2. Jan 29

   Clinical data

   24h Move

   -68.0%

   Positive 6-month REMAIN-1 midpoint data with favorable weight maintenance signals.

3. Jan 06

   Management change

   24h Move

   -2.9%

   Appointment of new CFO to support commercial-stage preparedness.

4. Jan 05

   Strategic roadmap

   24h Move

   -8.4%

   2026 clinical and regulatory roadmap with reported cash position and key milestones.

5. Dec 15

   Warrant call

   24h Move

   -3.6%

   Call of Tranche A warrants tied to earlier clinical success and trading milestones.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

type 2 diabetes

1 terms

type 2 diabetes medical

"focused on pioneering novel approaches to treat obesity and type 2 diabetes"

Type 2 diabetes is a chronic condition where the body struggles to control blood sugar levels because it becomes less responsive to insulin, a hormone that helps regulate sugar in the blood. It matters to investors because it can lead to increased healthcare costs, affect workforce productivity, and influence the performance of companies in the healthcare and pharmaceutical sectors. Managing or preventing the condition has significant implications for public health and economic stability.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes, today announced that it will report financial results for the fourth quarter and full year 2025 and provide business updates on Tuesday, March 24, 2026, at 4:30 p.m. ET.

A live webcast of the conference call and presentation can be accessed in the “Events” section of Fractyl Health’s website at http://ir.fractyl.com. The webcast will be archived and available for replay following the live event.

About Fractyl Health        

Fractyl Health is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes. Our Revita® and Rejuva® candidates are designed to target root causes of metabolic diseases, allowing us to advance metabolic disease treatment from chronic management towards prevention and reversal of disease. Fractyl is headquartered in Burlington, Massachusetts.

Contact 

Brian Luque, Head of Investor Relations and Corporate Development
IR@fractyl.com, 951.206.1200

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Fractyl Health (GUTS) report Q4 and full year 2025 results?

Fractyl Health will report results on March 24, 2026 at 4:30 p.m. ET. According to the company, the announcement includes fourth quarter and full year 2025 financial results plus business updates and a live webcast.

How can investors access the Fractyl Health (GUTS) March 24, 2026 webcast?

Investors can access the live webcast via the company’s Events page at http://ir.fractyl.com. According to the company, the presentation will be streamed live and then archived for replay after the event.

Will the Fractyl Health (GUTS) March 24 presentation be available after the live event?

Yes, the webcast will be archived and available for replay following the live event. According to the company, investors can view the archived presentation on the Events section of its investor website.

What will Fractyl Health (GUTS) cover during the March 24, 2026 business update?

Fractyl Health will provide business updates alongside its financial results on March 24, 2026. According to the company, the presentation will summarize recent corporate developments and progress in its clinical-stage metabolic therapeutics programs.

Is there a specific time for Fractyl Health (GUTS) investor call on March 24, 2026?

Yes, the investor call and presentation begin at 4:30 p.m. ET on March 24, 2026. According to the company, a live webcast will accompany the call and be archived for later replay.